Breaking News: BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering in 2024!
Breaking News: BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering in 2024! PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of an underwritten…